True Wealth Design’s Regulus Therapeutics RGLS Stock Holding History

True Wealth Design’s Portfolio RGLS Stock Details RGLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-60	Closed	-$105	–	2791
2025 Q1	$105	Buy	+60	New	+$79	﹤0.01%	2176

Other funds holding RGLS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

True Wealth Design's RGLS Position: Q2 2025 in Review

True Wealth Design sold out of Regulus Therapeutics (RGLS) in Q2 2025, closing a stake of 60 shares — an estimated $105 sold.

True Wealth Design first reported a position in RGLS in Q1 2025 and held it in 1 quarter. The position peaked at $105 in Q1 2025. 0 funds tracked by Wall St. Rank hold RGLS as of Q2 2025.

True Wealth Design reported no remaining Regulus Therapeutics position as of Q2 2025 after selling out during the quarter.
True Wealth Design sold 60 Regulus Therapeutics shares in Q2 2025, an estimated $105.
True Wealth Design first reported a position in Regulus Therapeutics in Q1 2025 and held it in 1 quarter.
True Wealth Design's Regulus Therapeutics position peaked at $105 in Q1 2025.
0 funds tracked by Wall St. Rank held Regulus Therapeutics as of Q2 2025.

Based on True Wealth Design's 13F filing for Q2 2025, filed 6 Aug 2025.